Skip to content
DataLookout
Menu

NCT07918989

A Study of Different Skin Care Approaches to Prevent Skin Reactions in People With Breast Cancer Receiving Radiation Therapy After Mastectomy

StatusRecruiting
PhasePhase 2
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Rate of acute radiation dermatitis with most desquamation (ARD-MD)
Timeframe: 12 months

Arms and interventions

Arm 1: Mometasone furoateExperimental

An ARD prevention strategy that has demonstrated the ability to reduce significant radiation dermatitis during breast radiotherapy is the topical application of corticosteroid creams, including mometasone and betametasone

Arm 2: Mepitel FilmExperimental

The use of barrier films such as Mepitel Film, Hydrofilm, and StrataXRT, has also been demonstrated to be effective in reducing the risk of clinically significant ARD.

Arm 3: Bacterial decolonizationExperimental

Bacterial decolonization (BD) is a intervention that has been studied as an ARD prevention measure.

Drugs: Mometasone Furoate 1% Cream

Devices: Mepitel Film

Dietary supplements: Intranasal mupirocin

Other: Chlorhexidine body cleansing

Sites

7 sites in 1 country